MedTrace Logo

Studying Biomarkers in Samples From Young Patients With Rhabdoid Tumors

NCT01544569 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2016-05-18

No results posted yet for this study

Summary

RATIONALE: Studying samples of tissue from patients with rhabdoid tumors in the laboratory may help doctor learn more about changes that occur in DNA and identify genes related to cancer.

PURPOSE: This research trial studies biomarkers in samples from young patients with rhabdoid tumors.

Conditions

Interventions

GENETIC

DNA analysis

GENETIC

fluorescence in situ hybridization

GENETIC

gene expression analysis

GENETIC

gene mapping

GENETIC

microarray analysis

GENETIC

polymerase chain reaction

GENETIC

protein expression analysis

OTHER

laboratory biomarker analysis

OTHER

medical chart review

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Children's Oncology Group

    lead NETWORK

Principal Investigators

  • Elizabeth A. Mullen, MD · Dana-Farber Cancer Institute

Eligibility

Max Age
1 Year
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2016-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01544569 on ClinicalTrials.gov